Dr. Jonathan Thompson, Founder & Chief Medical Officer
Dr. Thompson practices General and Bariatric Surgery at UC Health. He is an Assistant Professor at the UC College of Medicine and currently serves as Information Technology & Quality Improvement Officer – UC Health Weight Loss Center. Dr. Thompson established and became Director of The Thompson Center at the University of Cincinnati Research Institute (2013). Jon had fellowships at the University of Missouri Biodesign Program in 2009, and the Fogarty Institute for Innovation in 2013.
Matt Sokany, President & Chief Executive Officer
Mr. Sokany has 35 years of experience in the Medical Device Market. He has spent 24 years with Ethicon and Ethicon Endo-Surgery in various roles of increasing responsibility in sales and marketing, including US Board Member of Ethicon Endo-Surgery. Matt has spent eight years in the Medical Device Startup industry delivering significant investor return highlighted by the successful launch and exit of New Wave Surgical to Covidien (now Medtronic).
Adam Dunki-Jacobs, Chief Operating Officer
Adam has 15 years of medical device experience in all phases: academic research, front-end market creation and design to market. Adam managed the Johnson & Johnson metabolic research collaborative with the University of Cincinnati and Harvard to enable front-end market creation. He was the Director of Engineering at Enable Injections where he led development of high volume design and manufacturing of a drug delivery device. At Ethicon Endo-Surgery, Adam led the open mechanical (stapling) IP portfolio strategy and was a subject matter expert (SME) in staple formation technology. He holds more than 35 U.S. published patents and applications in medical devices, 30 of these in stapling technology.
Ronald Galovich, Chief Commercial Officer
Ronald has 30 years of extensive experience in the Medical Device and Life Science Industries developing and leading global commercial organizations. He has held senior commercial leadership positions in Sales, Marketing and General Management throughout various organizations including Ethicon, a Johnson & Johnson company, Tyco Healthcare (now Medtronic), Zimmer Biomet, Baxter, and Steris. Ron has extensive global concept-commercialization experience having launched numerous novel and disruptive technologies in General Surgery, Minimally Invasive Surgery, Cardiovascular Surgery, Orthopedic Surgery, Women’s Health and Infection Prevention.
Peter Donato, Chief Financial Officer
Peter joined us as our CFO in May 2020. Peter has nearly three decades of experience including over 17 years of senior experience in healthcare. Notable companies where Peter served include: Genetesis as President and as board director leading early financing, reimbursement, and commercialization efforts. Peter was CFO at Assurex and co-led its sale to Myriad, and while CFO at Neuronetics, led its initial public offering. Other experience includes: Bovie, Cyberonics, and Iris after starting his career at Ernst & Young, General Motors, and Scotts-Miracle-Gro. Peter earned his bachelor’s degree in business administration and accounting from The Fisher School of Business at The Ohio State University. He received his MBA from the University of Akron. Mr. Donato is a licensed CPA.